Nurix Therapeutics (NRIX) Q3 2023 Earnings

12OctConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.87
-0.73
-0.59
-0.45

Details

Expected EPS
-0.76
Actual EPS
-0.68
Surprise EPS
0.08
Surprise Percent
+10.53%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.68 per share for Q3 2023.

0 Comments

Share your thoughts